OCULAR THERAPEUTIX, INC (OCUL) Form 10-K Annual Reports
OCULAR THERAPEUTIX, INC (OCUL) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: OCUL
CIK: 1393434
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerHolly Reeves
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-16 | 2026-10-14 | FORM 8-K | 0001104659-26-116617 | View SEC Doc Filr Page |
| 4 | 2026-10-13 | 2026-10-08 | OWNERSHIP DOCUMENT | 0001104659-26-115551 | View SEC Doc Filr Page |
| 144 | 2026-10-08 | — | 144 Filing | 0001950047-26-010123 | View SEC Doc Filr Page |
| 4 | 2026-10-06 | 2026-10-02 | OWNERSHIP DOCUMENT | 0001104659-26-114081 | View SEC Doc Filr Page |
| 4 | 2026-10-06 | 2026-10-02 | OWNERSHIP DOCUMENT | 0001104659-26-114080 | View SEC Doc Filr Page |
| 144 | 2026-10-02 | — | 144 Filing | 0001950047-26-009999 | View SEC Doc Filr Page |
| 144 | 2026-10-02 | — | 144 Filing | 0001950047-26-009997 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-31 | OWNERSHIP DOCUMENT | 0001104659-26-104727 | View SEC Doc Filr Page |
| 144 | 2026-08-31 | — | 144 Filing | 0001950047-26-008839 | View SEC Doc Filr Page |
| 4 | 2026-08-26 | 2026-08-24 | OWNERSHIP DOCUMENT | 0001104659-26-101674 | View SEC Doc Filr Page |
| 4 | 2026-08-26 | 2026-08-24 | OWNERSHIP DOCUMENT | 0001104659-26-101671 | View SEC Doc Filr Page |
| 4 | 2026-08-26 | 2026-08-24 | OWNERSHIP DOCUMENT | 0001104659-26-101670 | View SEC Doc Filr Page |
| 4 | 2026-08-26 | 2026-08-24 | OWNERSHIP DOCUMENT | 0001104659-26-101667 | View SEC Doc Filr Page |
| 144 | 2026-08-24 | — | 144 Filing | 0001950047-26-008630 | View SEC Doc Filr Page |
| 144 | 2026-08-24 | — | 144 Filing | 0001950047-26-008629 | View SEC Doc Filr Page |
| 144 | 2026-08-24 | — | 144 Filing | 0001950047-26-008628 | View SEC Doc Filr Page |
| 144 | 2026-08-24 | — | 144 Filing | 0001950047-26-008627 | View SEC Doc Filr Page |
| S-8 | 2026-08-03 | — | FORM S-8 | 0001104659-26-089474 | View SEC Doc Filr Page |
| 10-Q | 2026-08-03 | 2026-06-30 | 10-Q | 0001104659-26-089450 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-08-03 | FORM 8-K | 0001104659-26-089443 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-29 | — | SCHEDULE 13G/A Filing | 0002012383-26-002837 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-16 | OWNERSHIP DOCUMENT | 0001104659-26-075709 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | OWNERSHIP DOCUMENT | 0001104659-26-073589 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | OWNERSHIP DOCUMENT | 0001104659-26-073587 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | OWNERSHIP DOCUMENT | 0001104659-26-073586 | View SEC Doc Filr Page |